Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Akash Tewari is an analyst at Jefferies. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 06/28/2024
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 06/24/2024 | LLY | Buy Now | Eli Lilly and Co | $906.04 | 12.03% | $994 → $1015 | Maintains | Buy | Get Alert |
| 06/07/2024 | LLY | Buy Now | Eli Lilly and Co | $906.04 | 5.62% | $925 → $957 | Maintains | Buy | Get Alert |
| 04/09/2024 | ALKS | Buy Now | Alkermes | $24.10 | 107.47% | $42 → $50 | Maintains | Buy | Get Alert |
| 03/06/2024 | APGE | Buy Now | Apogee Therapeutics | $39.35 | 90.6% | $37 → $75 | Maintains | Buy | Get Alert |
| 03/05/2024 | APGE | Buy Now | Apogee Therapeutics | $39.35 | 141.42% | $46 → $95 | Maintains | Buy | Get Alert |
| 02/05/2024 | APLS | Buy Now | Apellis Pharmaceuticals | $38.90 | 105.66% | $68 → $80 | Upgrade | Hold → Buy | Get Alert |
| 12/11/2023 | SYRE | Buy Now | Spyre Therapeutics | $23.51 | 31.86% | → $31 | Initiates | → Buy | Get Alert |
| 12/06/2023 | ARVN | Buy Now | Arvinas | $26.62 | 50.26% | $32 → $40 | Upgrade | Hold → Buy | Get Alert |
| 11/28/2023 | REGN | Buy Now | Regeneron Pharmaceuticals | $1.05K | -10.85% | $935 → $937 | Maintains | Buy | Get Alert |
| 11/28/2023 | SLRN | Buy Now | Acelyrin | $4.41 | 172.11% | $15 → $12 | Maintains | Buy | Get Alert |
| 10/16/2023 | PFE | Buy Now | Pfizer | $27.97 | 39.44% | $38 → $39 | Upgrade | Hold → Buy | Get Alert |
| 08/09/2023 | LLY | Buy Now | Eli Lilly | $906.04 | -32.12% | → $615 | Upgrade | Hold → Buy | Get Alert |
| 08/08/2023 | APGE | Buy Now | Apogee Therapeutics | $39.35 | -13.6% | → $34 | Initiates | → Buy | Get Alert |
| 08/08/2023 | ENTA | Buy Now | Enanta Pharma | $12.97 | 38.78% | $49 → $18 | Downgrade | Buy → Hold | Get Alert |
| 08/08/2023 | APGE | Buy Now | Apogee Therapeutics | $39.35 | -26.3% | → $29 | Initiates | → Buy | Get Alert |
| 07/21/2023 | LLY | Buy Now | Eli Lilly | $906.04 | -52.54% | $408 → $430 | Maintains | Hold | Get Alert |
| 07/17/2023 | ARGX | Buy Now | argenx | $430.04 | 19.29% | $497 → $513 | Maintains | Buy | Get Alert |
| 06/07/2023 | TERN | Buy Now | Terns Pharma | $6.91 | 160.49% | → $18 | Initiates | → Buy | Get Alert |
| 05/30/2023 | SLRN | Buy Now | Acelyrin | $4.41 | 602.95% | → $31 | Initiates | → Buy | Get Alert |
| 04/20/2023 | RLAY | Buy Now | Relay Therapeutics | $6.52 | 91.72% | $16 → $12.5 | Upgrade | Underperform → Hold | Get Alert |
| 04/03/2023 | LLY | Buy Now | Eli Lilly | $906.04 | -65.79% | $290 → $310 | Maintains | Hold | Get Alert |
| 03/24/2023 | REGN | Buy Now | Regeneron Pharmaceuticals | $1.05K | -11.99% | $675 → $925 | Upgrade | Hold → Buy | Get Alert |
| 03/06/2023 | MRK | Buy Now | Merck & Co | $125.00 | — | → $125 | Initiates | → Buy | Get Alert |
| 03/06/2023 | BMY | Buy Now | Bristol-Myers Squibb | $41.62 | 48.97% | → $62 | Initiates | → Hold | Get Alert |
| 03/06/2023 | LLY | Buy Now | Eli Lilly | $906.04 | -67.99% | → $290 | Initiates | → Hold | Get Alert |
| 03/06/2023 | PFE | Buy Now | Pfizer | $27.97 | 53.74% | → $43 | Initiates | → Hold | Get Alert |
| 12/20/2022 | ZYME | Buy Now | Zymeworks BC | $8.51 | 29.26% | $7.7 → $11 | Upgrade | Hold → Buy | Get Alert |
| 12/16/2022 | THRD | Buy Now | Third Harmonic Bio | $12.63 | -71.5% | $30 → $3.6 | Downgrade | Buy → Hold | Get Alert |
| 12/12/2022 | ACRV | Buy Now | Acrivon Therapeutics | $5.80 | 193.1% | → $17 | Initiates | → Buy | Get Alert |
| 11/29/2022 | BMRN | Buy Now | Biomarin Pharmaceutical | $82.33 | 45.75% | $100 → $120 | Maintains | Buy | Get Alert |
| 11/11/2022 | EQRX | Buy Now | EQRx | — | — | $5.6 → $3.2 | Downgrade | Buy → Hold | Get Alert |
| 10/10/2022 | THRD | Buy Now | Third Harmonic Bio | $12.63 | 137.53% | → $30 | Initiates | → Buy | Get Alert |
| 09/09/2022 | REGN | Buy Now | Regeneron Pharmaceuticals | $1.05K | -35.78% | $536 → $675 | Upgrade | Underperform → Hold | Get Alert |
| 08/08/2022 | GBT | Buy Now | Global Blood Therapeutics | — | — | $68 → $68.5 | Downgrade | Buy → Hold | Get Alert |
| 06/21/2022 | ARVN | Buy Now | Arvinas | $26.62 | 57.78% | → $42 | Initiates | → Hold | Get Alert |
| 06/06/2022 | NBIX | Buy Now | Neurocrine Biosciences | $137.67 | -18.65% | → $112 | Assumes | → Buy | Get Alert |
| 06/06/2022 | RLAY | Buy Now | Relay Therapeutics | $6.52 | 99.39% | → $13 | Initiates | → Underperform | Get Alert |
| 06/06/2022 | REGN | Buy Now | Regeneron Pharmaceuticals | $1.05K | -49% | → $536 | Initiates | → Underperform | Get Alert |
| 03/18/2022 | EQRX | Buy Now | EQRx | — | — | → $5.6 | Initiates | → Buy | Get Alert |
